This trial is conducted in Europe and the United States of America (USA).
The purpose of this study is to test whether insulin detemir is a safe and at least as
effective alternative to insulin glargine for the control of blood glucose in basal/bolus
therapy in patients with type I diabetes.
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Kuopio University Hospital, Kuopio, Finland
Centre Hospitalier Saint-Louis, La Rochelle, France
Krankenhaus Bethanien, Hamburg, Germany
´t Lange Land Ziekenhuis, Zoetermeer, Netherlands
Danderyds Sjukhus, Stockholm, Sweden
San Diego, California 92161, United States
Huntington Beach, California 92646, United States
San Francisco, California 94143, United States
Inglewood, California 90301, United States
Irvine, California 92618, United States
La Jolla, California 92037, United States
Anaheim, California 92801, United States
Melbourne, Florida 32901, United States
Vero Beach, Florida 32960, United States
Hollywood, Florida 33021, United States
Tampa, Florida 33613, United States
Winter Park, Florida 32789, United States
Atlanta, Georgia 30309, United States
Idaho Falls, Idaho 83404, United States
Chicago, Illinois 60607, United States
Topeka, Kansas 66606, United States
Detroit, Michigan 48235, United States
St. Louis, Missouri 63110, United States
Omaha, Nebraska 68131, United States
Las Vegas, Nevada 89109, United States
Brick, New Jersey 08724, United States
Berlin, New Jersey 08009, United States
Asheville, North Carolina 28801, United States
Philadelphia, Pennsylvania 19107, United States
Dallas, Texas 75235, United States
Houston, Texas 77030, United States
Dallas, Texas 75390-8858, United States
San Antonio, Texas 78229, United States